应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
HIMS Hims & Hers Health Inc.
交易中 05-22 12:39:38 EDT
23.80
-0.21
-0.89%
最高
24.53
最低
23.67
成交量
724.84万
今开
24.06
昨收
24.01
日振幅
3.56%
总市值
54.99亿
流通市值
48.54亿
总股本
2.31亿
成交额
1.75亿
换手率
3.55%
流通股本
2.04亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
YieldMax HIMS期权收入策略ETF宣布每周派息0.2186美元
环球市场播报 · 05-22 02:48
YieldMax HIMS期权收入策略ETF宣布每周派息0.2186美元
Hims & Hers:若由持牌医疗保健提供者开具处方,个性化治疗方案起价为每月149加元
美股速递 · 05-21 21:00
Hims & Hers:若由持牌医疗保健提供者开具处方,个性化治疗方案起价为每月149加元
异动解读 | Hims & Hers Health盘中大跌6.72%,可转债发行及一季度业绩暴雷引发市场担忧
异动解读 · 05-18
异动解读 | Hims & Hers Health盘中大跌6.72%,可转债发行及一季度业绩暴雷引发市场担忧
Hims & Hers Health宣布发行3亿美元可转债后,盘前股价重挫5.6%
美股速递 · 05-18
Hims & Hers Health宣布发行3亿美元可转债后,盘前股价重挫5.6%
异动解读 | Hims & Hers Health盘前大跌5.87%,Q1财报意外巨亏及GLP-1业务转型承压
异动解读 · 05-18
异动解读 | Hims & Hers Health盘前大跌5.87%,Q1财报意外巨亏及GLP-1业务转型承压
Hims & Hers Health宣布拟发行可转换优先票据,以支持国际扩张并加速人工智能驱动平台投资
老虎资讯综合 · 05-18
Hims & Hers Health宣布拟发行可转换优先票据,以支持国际扩张并加速人工智能驱动平台投资
Hims & Hers Health, Inc.宣布拟发行可转换优先票据,以支持国际扩张并加速人工智能平台投资
美股速递 · 05-18
Hims & Hers Health, Inc.宣布拟发行可转换优先票据,以支持国际扩张并加速人工智能平台投资
异动解读 | Hims & Hers Health财报后股价盘中大跌5.03%
异动解读 · 05-13
异动解读 | Hims & Hers Health财报后股价盘中大跌5.03%
期权大单 | 美光科技期权放量1.8倍,看涨期权密集押注;英伟达股价创新高,交易热度攀升
老虎资讯综合 · 05-13
期权大单 | 美光科技期权放量1.8倍,看涨期权密集押注;英伟达股价创新高,交易热度攀升
市场观点:Hims & Hers的战略投资被视作长期优势
投资观察 · 05-13
市场观点:Hims & Hers的战略投资被视作长期优势
Hims & Hers公布一季度亏损、业绩指引疲软,股价暴跌15.2%
环球市场播报 · 05-13
Hims & Hers公布一季度亏损、业绩指引疲软,股价暴跌15.2%
市场聚焦:游戏驿站、Venture Global、温蒂汉堡、Hims & Hers等个股动态
投资观察 · 05-12
市场聚焦:游戏驿站、Venture Global、温蒂汉堡、Hims & Hers等个股动态
关注焦点:Venture Global、Hims & Hers、GoPro等个股动态
投资观察 · 05-12
关注焦点:Venture Global、Hims & Hers、GoPro等个股动态
异动解读 | Hims & Hers Health盘前大跌16.09%,因Q1财报意外亏损、GLP-1供应链减记及目标价遭下调
异动解读 · 05-12
异动解读 | Hims & Hers Health盘前大跌16.09%,因Q1财报意外亏损、GLP-1供应链减记及目标价遭下调
异动解读 | Hims & Hers Health夜盘大跌13.49%,因Q1营收未达预期且意外亏损
异动解读 · 05-12
异动解读 | Hims & Hers Health夜盘大跌13.49%,因Q1营收未达预期且意外亏损
Hims & Hers Health Q1营收同比增长4%,但盈利未达预期出现亏损
老虎资讯综合 · 05-12
Hims & Hers Health Q1营收同比增长4%,但盈利未达预期出现亏损
Hims高管坦言肽类产品或非市场首发,但力求上市即实现规模化供应
美股速递 · 05-12
Hims高管坦言肽类产品或非市场首发,但力求上市即实现规模化供应
Hims高管称公司因GLP-1供应链减记产生约3300万美元重组成本 - 电话会议
美股速递 · 05-12
Hims高管称公司因GLP-1供应链减记产生约3300万美元重组成本 - 电话会议
Hims & Hers Health首席财务官称,转向FDA批准的GLP-1药物后公司网站访问量与应用程序下载量创下纪录
美股速递 · 05-12
Hims & Hers Health首席财务官称,转向FDA批准的GLP-1药物后公司网站访问量与应用程序下载量创下纪录
Hims & Hers Health因复合GLP-1药物原料及库存计提减值,并确认一次性并购成本——首席财务官披露
美股速递 · 05-12
Hims & Hers Health因复合GLP-1药物原料及库存计提减值,并确认一次性并购成本——首席财务官披露
暂无数据
公司概况
公司名称:
Hims & Hers Health Inc.
所属市场:
NYSE
上市日期:
--
主营业务:
Hims & Hers Health Inc是一家多专业远程医疗平台,将消费者与持牌医疗保健专业人员联系起来,使他们能够获得与心理健康、性健康、皮肤病学、头发护理等相关的多种疾病的高质量医疗服务。
发行价格:
--
{"stockData":{"symbol":"HIMS","market":"US","secType":"STK","nameCN":"Hims & Hers Health Inc.","latestPrice":23.7961,"timestamp":1779467976580,"preClose":24.01,"halted":0,"volume":7248420,"delay":0,"changeRate":-0.008908788004998018,"floatShares":204000000,"shares":231071031,"eps":-0.09,"marketStatus":"交易中","change":-0.2139,"latestTime":"05-22 12:39:38 EDT","open":24.06,"high":24.525,"low":23.67,"amount":174730390.77473998,"amplitude":0.03561,"askPrice":23.8,"askSize":224,"bidPrice":23.78,"bidSize":124,"shortable":3,"etf":0,"ttmEps":-0.09,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1779480000000},"marketStatusCode":2,"adr":0,"exchange":"NYSE","adjPreClose":24.01,"preHourTrading":{"tag":"盘前","latestPrice":24.14,"preClose":24.01,"latestTime":"09:29 EDT","volume":155176,"amount":3724920.119536,"timestamp":1779456592909,"change":0.13,"changeRate":0.005414,"amplitude":0.017493},"postHourTrading":{"tag":"盘后","latestPrice":24.09,"preClose":24.01,"latestTime":"19:59 EDT","volume":506206,"amount":12178434.1492,"timestamp":1779407979335,"change":0.08,"changeRate":0.003332,"amplitude":0.018326},"volumeRatio":0.663769,"optionData":{"bulkOrders":[{"symbol":"HIMS","call":true,"expireDate":1784260800000,"strike":"29.0","timestamp":1779459740980,"price":1.43,"volume":4000,"amount":572000,"type":"+"},{"symbol":"HIMS","call":true,"expireDate":1779422400000,"strike":"24.5","timestamp":1779462966988,"price":0.04,"volume":2000,"amount":8000,"type":"+"}]},"impliedVol":0.3795,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/HIMS/tweets","defaultTab":"tweets","newsList":[{"id":"2637356053","title":"YieldMax HIMS期权收入策略ETF宣布每周派息0.2186美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2637356053","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637356053?lang=zh_cn&edition=full","pubTime":"2026-05-22 02:48","pubTimestamp":1779389280,"startTime":"0","endTime":"0","summary":"YieldMax HIMS期权收入策略ETF于5月21日宣布进行每周股息分配,每股派息金额为0.2186美元,交易代码为HIYY。除息日及登记日均为5月21日,支付日为5月22日。 该基金于2025年9月25日在NYSE Arca交易所上市,由Tidal Investments LLC担任投资顾问,是一只主动管理型ETF。 根据YieldMax官网披露的数据,HIYY的管理资产规模约为2596万美元,总费用率为0.99%,30天SEC收益率为2.58%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-22/doc-inhysxpc7980480.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["HIYY","HMYY","BK4588","HIMY","BK4196","HIMS","HIMZ","BK4585","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188484570","title":"Hims & Hers:若由持牌医疗保健提供者开具处方,个性化治疗方案起价为每月149加元","url":"https://stock-news.laohu8.com/highlight/detail?id=1188484570","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188484570?lang=zh_cn&edition=full","pubTime":"2026-05-21 21:00","pubTimestamp":1779368443,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc. 宣布,其个性化治疗方案,在获得持牌医疗保健提供者开具处方的前提下,每月费用从149加元起。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMZ","BK4196","HIYY","HIMY","HMYY","HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133738631","title":"异动解读 | Hims & Hers Health盘中大跌6.72%,可转债发行及一季度业绩暴雷引发市场担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1133738631","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133738631?lang=zh_cn&edition=full","pubTime":"2026-05-18 21:42","pubTimestamp":1779111775,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc. (HIMS) 今日盘中股价大幅下挫6.72%,市场抛售情绪明显。消息面上,公司宣布计划发行总额高达3亿美元的可转换优先票据,以支持国际扩张和人工智能平台投资。此举引发了市场对现有股东权益可能被稀释的广泛担忧,成为股价下跌的直接导火索。与此同时,公司此前公布的第一季度财报表现远逊于市场预期,每股亏损0.40美元,而市场原本预期为盈利;净亏损高达9200万美元,同比大幅扩大。此外,公司在GLP-1减肥药业务上的战略转型,即从销售自有仿制药转为分销品牌药,也对短期利润率构成了压力。多重利空因素叠加,共同导致了本次股价的剧烈波动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2236282cca30ad73f1d67aa4598fc9cd","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183051628","title":"Hims & Hers Health宣布发行3亿美元可转债后,盘前股价重挫5.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1183051628","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183051628?lang=zh_cn&edition=full","pubTime":"2026-05-18 19:22","pubTimestamp":1779103358,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc.股价在盘前交易中大幅下挫5.6%,此前该公司宣布计划发行总额高达3亿美元的可转换优先票据。这一融资举措引发了市场对其股权稀释风险的担忧,导致投资者抛售股票。可转换债券通常允许持有人在特定条件下将其转换为公司普通股,此举虽能为公司筹集资金以支持业务扩张或偿还债务,但也可能在未来摊薄现有股东的权益。市场反应迅速且负面,反映出在当前环境下,投资者对这类融资行为的高度敏感。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"93212f33d248d5e91c2fed6135604e8d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMZ","HMYY","BK4196","HIMY","HIMS","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148282899","title":"异动解读 | Hims & Hers Health盘前大跌5.87%,Q1财报意外巨亏及GLP-1业务转型承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1148282899","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148282899?lang=zh_cn&edition=full","pubTime":"2026-05-18 19:19","pubTimestamp":1779103159,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc. (HIMS) 今日盘前股价大跌5.87%,引发了市场的广泛关注。消息面上,公司此前公布的第一季度财报大幅逊于预期,每股亏损0.40美元,而市场预期为盈利;净亏损达9200万美元,同比扩大近一倍。营收也低于市场预期,其中美洲地区营收同比下降成为主要拖累。此外,公司此前推出的诺和诺德Wegovy仿制药因诉讼及监管审查被迫撤回,已转为与诺和诺德合作分销品牌GLP-1产品,放弃了利润更高的自有替代品,短期内对利润率构成压力。摩根大通也因此下调了其目标价。这些因素共同导致了市场对公司短期业绩和盈利能力的担忧,从而引发了盘前股价的大幅下跌。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146794300","title":"Hims & Hers Health宣布拟发行可转换优先票据,以支持国际扩张并加速人工智能驱动平台投资","url":"https://stock-news.laohu8.com/highlight/detail?id=1146794300","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146794300?lang=zh_cn&edition=full","pubTime":"2026-05-18 19:18","pubTimestamp":1779103111,"startTime":"0","endTime":"0","summary":"5月18日,Hims & Hers Health跌超6%!宣布拟发行可转换优先票据,以支持国际扩张并加速人工智能驱动平台投资。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"93212f33d248d5e91c2fed6135604e8d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers Health宣布拟发行可转换优先票据,以支持国际扩张并加速人工智能驱动平台投资","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1156609848","title":"Hims & Hers Health, Inc.宣布拟发行可转换优先票据,以支持国际扩张并加速人工智能平台投资","url":"https://stock-news.laohu8.com/highlight/detail?id=1156609848","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156609848?lang=zh_cn&edition=full","pubTime":"2026-05-18 19:17","pubTimestamp":1779103037,"startTime":"0","endTime":"0","summary":"Hims & Hers Health, Inc. 今日公布了一项拟议的可转换优先票据发行计划。此次融资旨在为公司两大战略重点注入资金:一是推动其健康服务平台的国际版图扩张,二是加速对人工智能驱动平台的深度投资。\n通过发行此类票据,公司期望在强化资产负债表的同时,获得长期资本以把握增长机遇。此举不仅有助于其将创新的远程医疗与个性化健康解决方案推向全球更多市场,也将进一步整合先进的人工智能技术,以优化用户体验并提升服务效率。\n市场分析认为,这笔融资若成功完成,将为Hims & Hers下一阶段的规模化发展提供关键动力,使其在竞争日益激烈的数字健康领域巩固技术优势并拓展市场份额。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"93212f33d248d5e91c2fed6135604e8d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMZ","HIMS","HMYY","HIYY","HIMY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188810296","title":"异动解读 | Hims & Hers Health财报后股价盘中大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=1188810296","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188810296?lang=zh_cn&edition=full","pubTime":"2026-05-13 21:57","pubTimestamp":1778680644,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc. (HIMS) 今日盘中股价大跌5.03%,引起市场关注。消息面上,该公司近期发布财报后股价出现显著下跌,市场对其业绩表现可能存有担忧,这或为今日股价下跌的背景因素。此外,期权市场数据显示,HIMS的期权合约成交较90日均量放大1.9倍,表明市场对该股票的交易兴趣和波动性预期上升。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115830998","title":"期权大单 | 美光科技期权放量1.8倍,看涨期权密集押注;英伟达股价创新高,交易热度攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=1115830998","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115830998?lang=zh_cn&edition=full","pubTime":"2026-05-13 11:42","pubTimestamp":1778643774,"startTime":"0","endTime":"0","summary":"期权市场总成交量61,412,266张合约,其中看涨期权占比59%。另外,英伟达将于5月20日盘后公布第一季度财报。花旗银行发布前瞻报告,预计英伟达本季度营收将达约730亿美元,超出市场普遍预期的约718亿美元约14亿美元。5月15日到期的800美元的行权看涨期权交易量特别高,共有39,120份合约交易。","market":"us","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4a24c217715bcb751b39ba2fdad7cf5d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MULL","NVII","MUD","HIMY","MU","NVDS","INTC","NVDA","NVDL","ANV","NVDD","NVYY","LINT","NVD","NVDW","NVDG","MUU","NVDX","NVDY","NVDO","HMYY","NVDU","HIMS","NVDQ","DIPS","HIMZ","HIYY","NVDB","INTW"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1187486297","title":"市场观点:Hims & Hers的战略投资被视作长期优势","url":"https://stock-news.laohu8.com/highlight/detail?id=1187486297","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187486297?lang=zh_cn&edition=full","pubTime":"2026-05-13 01:40","pubTimestamp":1778607657,"startTime":"0","endTime":"0","summary":"美国银行证券的分析师指出,Hims & Hers Health Inc. 正经历又一个高投入的年份,这对其利润率构成了压力。然而,这些战略性投资有望成为这家远程医疗公司的长期差异化优势。分析师们特别看好该公司在垂直整合供应链和拓展国际业务方面所做的投入。受此影响,Hims & Hers Health Inc. 股价当日大幅下挫近14%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"89a4eb0c97016e8640c4422499c1632e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIYY","HIMZ","HIMY","HIMS","BK4196","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635246753","title":"Hims & Hers公布一季度亏损、业绩指引疲软,股价暴跌15.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635246753","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635246753?lang=zh_cn&edition=full","pubTime":"2026-05-13 00:46","pubTimestamp":1778604360,"startTime":"0","endTime":"0","summary":" 数字医疗公司 Hims & Hers 周二受一季度财报疲软拖累,股价大幅下挫。 公司一季度净亏损达 9200 万美元,高于去年同期的 5000 万美元。该公司近期与诺和诺德达成合作,将在平台销售其品牌减肥药。 远程医疗企业 Hims & Hers 发布一季度亏损业绩,且全年业绩指引偏弱,周二股价应声大跌。 该股最新跌幅15.2%。 “这次合作和上次完全不同。Hims & Hers 已承诺,在上架我方正品后,不再向大众宣传、推广复方仿制类减肥药。”","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-13/doc-inhxsiea9781441.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0154236417.USD","LU1093756325.SGD","IE00BKVL7J92.USD","NVOX","BK4588","BK4585","HIMS","BK4599","NVOH","LU1093756168.USD","IE00BZ1G4Q59.USD","BK4007","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137321098","title":"市场聚焦:游戏驿站、Venture Global、温蒂汉堡、Hims & Hers等个股动态","url":"https://stock-news.laohu8.com/highlight/detail?id=1137321098","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137321098?lang=zh_cn&edition=full","pubTime":"2026-05-12 20:09","pubTimestamp":1778587787,"startTime":"0","endTime":"0","summary":"游戏驿站 :这家视频游戏零售商的董事会拒绝了eBay主动提出的560亿美元收购要约,其股价在盘前交易中应声下跌。Venture Global :这家液化天然气出口商报告第一季度营收和利润大幅增长后,其股价在盘前交易中上涨了9%。Hims & Hers :这家远程医疗平台的股价在盘前下跌了15%,原因是该公司表示,其调整减肥产品线的举措推高了成本。ZoomInfo Technologies Inc. :这家市场情报公司的股价在周一晚些时候下调全年业绩指引后大幅下挫。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c1ee3020066801ecc9807d71c3848eaf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GMEU","BK4023","NVO","HIMS","VG","GPRO","BK4202","IE00BZ1G4Q59.USD","BK4007","GMEY","BK4209","BK4577","BK4077","GTM","HIMY","LU1093756325.SGD","BK4588","IGME","NVOH","BK4076","UA","BK4078","WEN","HIMZ","IE00BKVL7J92.USD","BK4213","LU0154236417.USD","BK4196","BK4599","GME","HMYY","BK4532","HIYY","LU1093756168.USD","BK4585","BAYRY","BK4547","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110023794","title":"关注焦点:Venture Global、Hims & Hers、GoPro等个股动态","url":"https://stock-news.laohu8.com/highlight/detail?id=1110023794","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110023794?lang=zh_cn&edition=full","pubTime":"2026-05-12 17:18","pubTimestamp":1778577489,"startTime":"0","endTime":"0","summary":"液化天然气出口商Venture Global Inc. 将于今日早间公布财报。由于霍尔木兹海峡关闭,该公司有望从中受益,其业绩或将揭示当前市场需求的实际强度。该股在盘前交易中已出现上涨。远程医疗平台Hims & Hers Health Inc. 的股价在盘前重挫逾15%。此前,该公司表示,其对减肥产品线的调整重组导致成本上升。运动品牌Under Armour 和On Holding AG 预计将于今日发布财报。市场情报公司ZoomInfo Technologies Inc. 股价暴跌。该公司于周一晚间下调了其全年业绩指引。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","NVO","LU0289961442.SGD","BK4078","LU0154236417.USD","BK4532","NVOX","LU0069063385.USD","BK4213","NVOH","IE00BKVL7J92.USD","BAYRY","IE00BZ1G4Q59.USD","HMYY","LU0057025933.USD","BK4599","ONON","BK4547","HIMY","LU2265009873.SGD","BK4007","BK4202","HIMZ","BK4196","VG","LU0511384066.AUD","GPRO","LU0472753341.HKD","BK4023","HIMS","GTM","HIYY","LU1093756168.USD","LU1804176565.USD","BK4588","BK4146","LU0289739343.SGD","UA","BK4077","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112435267","title":"异动解读 | Hims & Hers Health盘前大跌16.09%,因Q1财报意外亏损、GLP-1供应链减记及目标价遭下调","url":"https://stock-news.laohu8.com/highlight/detail?id=1112435267","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112435267?lang=zh_cn&edition=full","pubTime":"2026-05-12 16:11","pubTimestamp":1778573466,"startTime":"0","endTime":"0","summary":"远程医疗公司Hims & Hers Health Inc.今日盘前股价大幅下挫16.09%,引发了市场的广泛关注。消息面上,此次股价下跌主要源于公司盘后公布的第一季度财报表现远逊于市场预期。美洲地区营收同比下降8%至5.299亿美元,成为拖累整体业绩的主因。此外,公司的战略调整带来了显著的财务影响。与此同时,摩根大通将公司目标价从35美元下调至33美元,进一步加剧了市场的悲观情绪。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"89a4eb0c97016e8640c4422499c1632e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135827693","title":"异动解读 | Hims & Hers Health夜盘大跌13.49%,因Q1营收未达预期且意外亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=1135827693","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135827693?lang=zh_cn&edition=full","pubTime":"2026-05-12 08:02","pubTimestamp":1778544132,"startTime":"0","endTime":"0","summary":"远程医疗公司Hims & Hers Health Inc. 今日夜盘股价大幅下挫13.49%,引发了市场广泛关注。此次股价下跌主要源于公司盘后公布的第一季度财报表现远逊于市场预期。美洲地区营收同比下降8%至5.299亿美元,成为拖累整体业绩的主因。消息面上,公司的战略调整带来了显著的财务影响。尽管公司同时上调了2026年全年营收预期至28-30亿美元,并预计在2027年恢复盈利,但第一季度的意外亏损和营收未达预期仍是股价承压的直接导火索。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"89a4eb0c97016e8640c4422499c1632e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1194384043","title":"Hims & Hers Health Q1营收同比增长4%,但盈利未达预期出现亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=1194384043","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194384043?lang=zh_cn&edition=full","pubTime":"2026-05-12 06:23","pubTimestamp":1778538229,"startTime":"0","endTime":"0","summary":"5月12日,Hims & Hers Health盘后暴跌逾12%!第一季度盈利未达预期,出现亏损,原因是其美国业务疲软抵消了海外业务的增长。2026年第一季度营收为6.081亿美元,高于2025年第一季度的5.86亿美元,同比增长4%。今年2月,该公司推出了诺和诺德公司Wegovy片剂的仿制药,但由于诺和诺德提起诉讼以及监管机构加强审查,该公司随后撤回了该产品。目前,该公司与诺和诺德合作分销其品牌的GLP-1受体激动剂,并同意停止销售其自身价格更低、利润更高的替代产品。","market":"us","thumbnail":"https://static.tigerbbs.com/f3698e3114ac0a5c39dcf7c045f5aaf4","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f3698e3114ac0a5c39dcf7c045f5aaf4"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ca0e3dea87604e6a95a3bf5695c5bcab","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers Health Q1营收同比增长4%,但盈利未达预期出现亏损","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","HIMZ","HMYY","HIYY","HIMS"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1176659107","title":"Hims高管坦言肽类产品或非市场首发,但力求上市即实现规模化供应","url":"https://stock-news.laohu8.com/highlight/detail?id=1176659107","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176659107?lang=zh_cn&edition=full","pubTime":"2026-05-12 06:23","pubTimestamp":1778538215,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc. 的一位高管表示,公司可能不会成为肽类产品市场的先行者,但其目标是在产品推出时便能实现规模化供应。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMZ","BK4196","HMYY","HIMS","HIMY","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130276246","title":"Hims高管称公司因GLP-1供应链减记产生约3300万美元重组成本 - 电话会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1130276246","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130276246?lang=zh_cn&edition=full","pubTime":"2026-05-12 05:28","pubTimestamp":1778534931,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc. 的一位高管在电话会议中透露,公司因GLP-1相关供应链资产减记而产生了大约3300万美元的重组费用。这一成本反映了公司在调整其业务结构以应对市场变化时所面临的财务影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"89a4eb0c97016e8640c4422499c1632e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMY","HMYY","HIYY","OZEM","HIMZ","BK4196","HIMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169029796","title":"Hims & Hers Health首席财务官称,转向FDA批准的GLP-1药物后公司网站访问量与应用程序下载量创下纪录","url":"https://stock-news.laohu8.com/highlight/detail?id=1169029796","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169029796?lang=zh_cn&edition=full","pubTime":"2026-05-12 04:46","pubTimestamp":1778532419,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc. 的首席财务官表示,在公司业务重心转向提供经美国食品药品监督管理局批准的GLP-1类药物后,其数字平台迎来了前所未有的访问流量,同时移动应用程序的下载量也飙升至历史新高。这一战略转型显著提升了用户参与度,反映出市场对这类获批减肥与糖尿病药物的强劲需求。随着GLP-1药物持续受到关注,Hims & Hers Health 有望进一步巩固其在直接面向消费者健康领域的市场地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","HMYY","HIYY","HIMY","BK4196","HIMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162620391","title":"Hims & Hers Health因复合GLP-1药物原料及库存计提减值,并确认一次性并购成本——首席财务官披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1162620391","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162620391?lang=zh_cn&edition=full","pubTime":"2026-05-12 04:44","pubTimestamp":1778532279,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc. 的首席财务官透露,公司对与复合GLP-1药物相关的原料及库存进行了资产减值计提,同时确认了与并购相关的一次性成本。这些财务处理反映了公司在特定业务领域的调整以及对过往投资项目的评估。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"89a4eb0c97016e8640c4422499c1632e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIYY","BK4196","HIMS","HIMZ","HIMY","HMYY"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0095},{"period":"1month","weight":-0.1932},{"period":"3month","weight":0.5361},{"period":"6month","weight":-0.3083},{"period":"1year","weight":-0.586},{"period":"ytd","weight":-0.2605}],"compareEarnings":[{"period":"1week","weight":-0.0073},{"period":"1month","weight":0.0549},{"period":"3month","weight":0.0773},{"period":"6month","weight":0.127},{"period":"1year","weight":0.2743},{"period":"ytd","weight":0.0892}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Hims & Hers Health Inc是一家多专业远程医疗平台,将消费者与持牌医疗保健专业人员联系起来,使他们能够获得与心理健康、性健康、皮肤病学、头发护理等相关的多种疾病的高质量医疗服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.098962},{"month":2,"riseRate":0.571429,"avgChangeRate":0.066017},{"month":3,"riseRate":0.428571,"avgChangeRate":0.011001},{"month":4,"riseRate":0.428571,"avgChangeRate":0.018546},{"month":5,"riseRate":0.428571,"avgChangeRate":0.147658},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.021115},{"month":7,"riseRate":0.666667,"avgChangeRate":0.073238},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.14623},{"month":9,"riseRate":0.5,"avgChangeRate":0.080437},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.073266},{"month":11,"riseRate":0.714286,"avgChangeRate":0.187933},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.001486}],"exchange":"NYSE","name":"Hims & Hers Health Inc.","nameEN":"Hims & Hers Health Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Hims & Hers Health Inc.(HIMS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Hims & Hers Health Inc.(HIMS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Hims & Hers Health Inc.,HIMS,Hims & Hers Health Inc.股票,Hims & Hers Health Inc.股票老虎,Hims & Hers Health Inc.股票老虎国际,Hims & Hers Health Inc.行情,Hims & Hers Health Inc.股票行情,Hims & Hers Health Inc.股价,Hims & Hers Health Inc.股市,Hims & Hers Health Inc.股票价格,Hims & Hers Health Inc.股票交易,Hims & Hers Health Inc.股票购买,Hims & Hers Health Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Hims & Hers Health Inc.(HIMS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Hims & Hers Health Inc.(HIMS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}